251 related articles for article (PubMed ID: 26518415)
1. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
Ou B; Zhao J; Guan S; Lu A
Dig Dis Sci; 2016 Mar; 61(3):881-9. PubMed ID: 26518415
[TBL] [Abstract][Full Text] [Related]
2. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
Adams SV; Ahnen DJ; Baron JA; Campbell PT; Gallinger S; Grady WM; LeMarchand L; Lindor NM; Potter JD; Newcomb PA
World J Gastroenterol; 2013 Jun; 19(21):3241-8. PubMed ID: 23745025
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
4. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
5. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer: A Systematic Review and Meta-analysis.
Lu C; Schardey J; Zhang T; Crispin A; Wirth U; Karcz KW; Bazhin AV; Andrassy J; Werner J; Kühn F
Ann Surg; 2022 Nov; 276(5):e319-e330. PubMed ID: 34913897
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
[TBL] [Abstract][Full Text] [Related]
7. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival.
Taylor CC; Millien VO; Hou JK; Massarweh NN
J Surg Res; 2020 Mar; 247():77-85. PubMed ID: 31767275
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
Bogach J; Pond G; Eskicioglu C; Seow H
Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
Ali RA; Dooley C; Comber H; Newell J; Egan LJ
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
[TBL] [Abstract][Full Text] [Related]
10. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease.
Parian A; Koh J; Limketkai BN; Eluri S; Rubin DT; Brant SR; Ha CY; Bayless TM; Giardiello F; Hart J; Montgomery E; Lazarev MG
Gastrointest Endosc; 2016 Jul; 84(1):87-95.e1. PubMed ID: 26709112
[TBL] [Abstract][Full Text] [Related]
11. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
[TBL] [Abstract][Full Text] [Related]
12. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
Li H; Jin Z; Li X; Wu L; Jin J
Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
[TBL] [Abstract][Full Text] [Related]
13. The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
Peng YC; Lin CL; Sung FC
PLoS One; 2017; 12(5):e0177745. PubMed ID: 28549071
[TBL] [Abstract][Full Text] [Related]
14. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
Jess T; Lopez A; Andersson M; Beaugerie L; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1793-1800.e1. PubMed ID: 24907505
[TBL] [Abstract][Full Text] [Related]
15. Stage at Diagnosis and Survival of Colorectal Cancer With or Without Underlying Inflammatory Bowel Disease: A Population-based Study.
Arhi C; Askari A; Nachiappan S; Bottle A; Arebi N; Athanasiou T; Ziprin P; Aylin P; Faiz O
J Crohns Colitis; 2021 Mar; 15(3):375-382. PubMed ID: 32991688
[TBL] [Abstract][Full Text] [Related]
16. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
18. Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer.
Brackmann S; Aamodt G; Andersen SN; Roald B; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Inflamm Bowel Dis; 2010 Mar; 16(3):474-81. PubMed ID: 19714748
[TBL] [Abstract][Full Text] [Related]
19. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]